Cardiovascular risk and events after liver transplantation. Experiences from 313 consecutive transplants with a follow-up of 20 years

Clinical Transplantation

Volumn 29, Issue 4, 2015, Pages 343-350

  Schoening, Wenzel ^a   Neidel, Nadja ^a   Buescher, Niklas ^a   Andreou, Andreas ^a   Pascher, Andreas ^a   Seehofer, Daniel ^a   Bahra, Marcus ^a   Schmitz, Volker ^a   Pratschke, Johann ^a   Puhl, Gero ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Cardiovascular risk; Liver transplantation; Long term follow up

Indexed keywords

AZATHIOPRINE; CALCINEURIN INHIBITOR; CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; ISCHEMIC HEART DISEASE; KIDNEY FUNCTION; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL; PROCAM SCORE; RETROSPECTIVE STUDY; SUDDEN CARDIAC DEATH; ADVERSE EFFECTS; CARDIOVASCULAR DISEASES; CLINICAL TRIAL; HEART FUNCTION TEST; LIVER FAILURE; LONGITUDINAL STUDY; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE; PROGNOSIS; PROSPECTIVE STUDY; RISK FACTOR; SEVERITY OF ILLNESS INDEX; TIME FACTOR;

ADULT; AGED; CARDIOVASCULAR DISEASES; FEMALE; FOLLOW-UP STUDIES; HEART FUNCTION TESTS; HUMANS; LIVER FAILURE; LIVER TRANSPLANTATION; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 84927771766     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/ctr.12520     Document Type: Article

References (25)

1. Schoening WN, Buescher N, Rademacher S et al. Twenty-year longitudinal follow-up after orthotopic liver transplantation: a single-center experience of 313 consecutive cases. Am J Transplant 2013: 13: 2384.
2. Jain A, Singhal A, Fontes P et al. One thousand consecutive primary liver transplants under tacrolimus immunosuppression: a 17- to 20-year longitudinal follow-up. Transplantation 2011: 91: 1025.
3. Borg MA, van der Wouden EJ, Sluiter WJ, Slooff MJ, Haagsma EB, van den Berg AP. Vascular events after liver transplantation: a long-term follow-up study. Transpl Int 2008: 21: 74.
4. Germani G, Theocharidou E, Adam R et al. Liver transplantation for acute liver failure in Europe: outcomes over 20 years from the ELTR database. J Hepatol 2012: 57: 288.
5. Duffy JP, Kao K, Ko CY et al. Long-term patient outcome and quality of life after liver transplantation: analysis of 20-year survivors. Ann Surg 2010: 252: 652.
6. Busuttil RW, Farmer DG, Yersiz H et al. Analysis of long-term outcomes of 3200 liver transplantations over two decades: a single-center experience. Ann Surg 2005: 241: 905; discussion 16-8.
7. Adam R, Karam V, Delvart V et al. Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR). J Hepatol 2012: 57: 675.
8. Parekh J, Corley DA, Feng S. Diabetes, hypertension and hyperlipidemia: prevalence over time and impact on long-term survival after liver transplantation. Am J Transplant 2012: 12: 2181.
9. Sheiner PA, Magliocca JF, Bodian CA et al. Long-term medical complications in patients surviving > or = 5 years after liver transplant. Transplantation 2000: 69: 781.
10. Watt KD. Metabolic syndrome: is immunosuppression to blame? Liver Transpl 2011: 17(Suppl 3): S38.
11. Laish I, Braun M, Mor E, Sulkes J, Harif Y, Ben Ari Z. Metabolic syndrome in liver transplant recipients: prevalence, risk factors, and association with cardiovascular events. Liver Transpl 2011: 17: 15.
12. Abbasoglu O, Levy MF, Brkic BB et al. Ten years of liver transplantation: an evolving understanding of late graft loss. Transplantation 1997: 64: 1801.
13. Assmann G, Cullen P, Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Münster (PROCAM) study. Circulation 2002: 105: 310.
14. Conroy RM, Pyörälä K, Fitzgerald AP et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003: 24: 987.
15. D' Agostino RBS, Vasan Rs Fau - Pencina MJ, Pencina Mj Fau - Wolf PA et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 2008: 117: 743.
16. Wilson PWF, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998: 97: 1837.
17. Guckelberger O, Byram A, Klupp J et al. Coronary event rates in liver transplant recipients reflect the increased prevalence of cardiovascular risk-factors. Transpl Int 2005: 18: 967.
18. Guckelberger O, Mutzke F, Glanemann M et al. Validation of cardiovascular risk scores in a liver transplant population. Liver Transpl 2006: 12: 394.
19. Assmann G, Schulte H, Cullen P, Seedorf U. Assessing risk of myocardial infarction and stroke: new data from the Prospective Cardiovascular Münster (PROCAM) study‡. Eur J Clin Invest 2007: 37: 925.
20. European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003: 21: 1011.
21. Forouhi NG, Balkau B, Borch-Johnsen K et al. The threshold for diagnosing impaired fasting glucose: a position statement by the European Diabetes Epidemiology Group. Diabetologia 2006: 49: 822.
22. Levey AS, Coresh J, Balk E et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003: 139: 137.
23. Johnston SD, Morris JK, Cramb R, Gunson BK, Neuberger J. Cardiovascular morbidity and mortality after orthotopic liver transplantation. Transplantation 2002: 73: 901.
24. Neal DA, Tom BD, Luan J et al. Is there disparity between risk and incidence of cardiovascular disease after liver transplant? Transplantation 2004: 77: 93.
25. McPherson S, Packer RR, Cameron JM, Howell DN, Roll JM. Biochemical marker of use is a better predictor of outcomes than self-report metrics in a contingency management smoking cessation analog study. Am J Addict 2014: 23: 15.